Security key
344174107
Foghorn Therapeutics Inc. - Common Stock, $0.0001 par value per share (FHTX)
CUSIP: 344174107
Q1 2021 13F Holders as of 31 Mar 2021
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 10,646,057
- Total 13F value
- $139,604,845
- Share change
- +33,499
- SEC-reported price per share
- $13.18
- Number of holders
- 43
- Value change
- -$678,194
- Number of buys
- 15
- Number of sells
- 18
- Shares outstanding
- 58,724,855
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2021
Institutions
43
Top holders
10
FHTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2021
Previous quarter: Q4 2020
Foghorn Therapeutics Inc. SEC filings
Foghorn Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 344174107
Recent filing periods:
Ownership snapshot
Top reported holders of FHTX - Foghorn Therapeutics Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Flagship Pioneering, LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
31 Dec 2020
13F
Lead comparable stake: 22%
Showing 1-6 of 15 holder rows.
Quick read
Flagship Pioneering, LLC leads the comparable SEC ownership view at 22%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Flagship Pioneering, LLC's linked filing trail.
Comparable ownership
Top 5
Flagship Pioneering, LLC
22%
FMR LLC
4.4%
Artal Group S.A.
2.9%
Euclidean Capital LLC
2.1%
Cormorant Asset Management, LP
1.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Flagship Pioneering, LLC |
13F
Company
|
22%
|
$256,905
12,674,120 shares
|
— | 31 Dec 2020 |
| FMR LLC |
13F
Company
|
4.4%
|
$50,118,000
2,580,634 shares
|
— | 31 Dec 2020 |
| Artal Group S.A. |
13F
Company
|
2.9%
|
$34,879,000
1,720,720 shares
|
— | 31 Dec 2020 |
| Euclidean Capital LLC |
13F
Company
|
2.1%
|
$25,566,000
1,261,261 shares
|
— | 31 Dec 2020 |
| Cormorant Asset Management, LP |
13F
Company
|
1.7%
|
$20,270,000
1,000,000 shares
|
— | 31 Dec 2020 |
| BlackRock Finance, Inc. |
13F
Company
|
1.1%
|
$13,626,000
672,204 shares
|
— | 31 Dec 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
43
Shares
10,646,057
Rows available
43
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2021 vs Q4 2020 Across Filers
Q4 2020 holders
45
Q1 2021 holders
43
Holder diff
-2
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 value | Q1 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend